Voyager Therapeutics Inc

VYGRNASDAQ · USD
3.09USD0.00 (+1.65%)
325

Voyager Therapeutics Inc (VYGR) Straddle

VYGR straddle scan found 5 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 69.0%.

Read more

Trading a VYGR straddle lets you take a pure volatility position on Voyager Therapeutics Inc without committing to a direction. Voyager Therapeutics Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate VYGR straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on VYGR profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Voyager Therapeutics Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the VYGR straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau program for the treatment of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, as well as for spinal muscular atrophy.

The company has collaboration and license agreements with Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. for the research, development, and commercialization of adeno-associated virus gene therapy products. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the VYGR straddle is the cleanest expression of that view. Our scanner prices every VYGR straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a VYGR straddle into a catalyst or short a VYGR straddle to harvest decay, the options straddle setups that matter are all in one place.

Jan 15, 20276.00$3.9812138%69.0%$9.98$2.030
Apr 16, 20273.00$2.1821238%66.3%$5.18$0.8364
Jan 15, 20274.00$3.3012138%41.1%$7.30$0.7026
Apr 16, 20276.00$5.9821238%7.8%$11.98$0.030
Jan 15, 20275.00$5.0812138%$10.08-$0.082

As of September 17, 2026

Find the right straddle before volatility moves

Track VYGR straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial